4//SEC Filing
Nolan Lisa 4
Accession 0001140361-19-001635
CIK 0001228627other
Filed
Jan 24, 7:00 PM ET
Accepted
Jan 25, 7:54 PM ET
Size
5.2 KB
Accession
0001140361-19-001635
Insider Transaction Report
Form 4
Nolan Lisa
Chief Business Officer
Transactions
- Award
Stock Option (right to buy)
2019-01-25+130,000→ 130,000 totalExercise: $0.62Exp: 2029-01-25→ Common Stock (130,000 underlying)
Footnotes (1)
- [F1]One quarter of the option vests and becomes exercisable on January 25, 2020, and, thereafter, 1/36th of the remaining option vests in equal installments on each monthly anniversary of such date until fully vested.
Documents
Issuer
REXAHN PHARMACEUTICALS, INC.
CIK 0001228627
Entity typeother
Related Parties
1- filerCIK 0001661400
Filing Metadata
- Form type
- 4
- Filed
- Jan 24, 7:00 PM ET
- Accepted
- Jan 25, 7:54 PM ET
- Size
- 5.2 KB